From basic and clinical research in the pathogenesis of depression (Alcocer-Gómez et al., 2014), it is clear that, in depression, there are higher levels of peripheral blood mononuclear cells of NLRP3 inflammasome product components. This evidence concerns the gene NLRP3 and depressive symptom measurement.